US EditionPublished • loading... • Updated
cbdMD Reports Third Consecutive Year of Operating Improvement, Strengthens Balance Sheet, and Regains NYSE American Continued Listing Compliance
cbdMD improved operations for the third consecutive year, reducing losses to $2.1 million and boosting net book value to $7.2 million through equity financings and cost management.
- On Dec. 19, 2025 in Charlotte, N.C., cbdMD, Inc. reported fiscal 2025 results showing a third consecutive year of operational improvement and restored NYSE American listing compliance.
- Citing operational moves, cbdMD highlighted disciplined cost management, focused execution and millions invested in GMP manufacturing and product testing to boost quality and science initiatives.
- Reported results reveal a loss from operations , net loss attributable to common shareholders , and $14.7 million in DTC net sales, with $2.3 million in cash at September 30, 2025.
- Securing a $20 million equity line of credit enabled the company to improve net book value to approximately $7.2 million, strengthening liquidity measures.
- Kennedy said the auditor's explanatory paragraph urges review of SEC filings, but with a stronger balance sheet and capital flexibility, cbdMD enters calendar 2026 in a materially stronger position.
Insights by Ground AI
37 Articles
37 Articles
The Berkshire Eagle+36 Reposted by 36 other sources
cbdMD Reports Third Consecutive Year of Operating Improvement, Strengthens Balance Sheet, and Regains NYSE American Continued Listing Compliance
CHARLOTTE, N.C., Dec. 19, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with hemp derived…
Coverage Details
Total News Sources37
Leaning Left3Leaning Right3Center12Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 17%
C 67%
R 16%
Factuality
To view factuality data please Upgrade to Premium
